Newsletter Signup | Join Community
Cancer Connect - Treatment of Recurrent Multiple Myeloma
May 2019 update on CAR T in multiple myeloma and other targeted therapies. CAR T looks very promising.
Velcade® Revlimid®/Dexamethasone A Bew Standard of Care for Newly Diagnosed Multiple Myeloma
Xgeva prevents bone complications and can delay the time to myeloma progression.
Revlimid is effective treatment for all stages of Multiple Myeloma. Understand the risk of developing a secondary cancer
Studies document the benefits—and risks of Revlimid, Ninlaro & Velcade maintenance therapy for Multiple Myeloma.
Monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma, and stage I multiple myeloma.
Has anyone elected to receive triple drug therapy and delay their ASCT? Seems like there is…
New Antibody that targets CD74 on myeloma cells gets nod from FDA to proceed. …
UK doctors identify a new target for treating Multiple Myeloma: …